Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens
Source abstract
Abstract
The design of biodegradable polymeric delivery systems based on polyanhydrides that would provide for improved structural integrity of Yersinia pestis antigens was the main goal of this study. Accordingly, the full-length Y. pestis fusion protein (F1-V) or a recombinant Y. pestis fusion protein (F1(B2T1)-V10) was encapsulated and released from microparticles based on 1,6-bis(p-carboxyphenoxy)hexane (CPH) and sebacic acid (SA) copolymers and 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG) and CPH copolymers fabricated by cryogenic atomization. An enzyme-linked immunosorbent assay was used to measure changes in the antigenicity of the released proteins. The recombinant F1(B2T1)-V10 was unstable upon release from the hydrophobic CPH:SA microparticles, but maintained its structure and antigenicity in the amphiphilic CPTEG:CPH system. The full-length F1-V was stably released by both CPH:SA and CPTEG:CPH microparticles. In order to determine the effect of the anhydride monomers on the protein structure, changes in the primary, secondary, and tertiary structure, as well as the antigenicity of both Y. pestis antigens, were measured after incubation in the presence of saturated solutions of SA, CPH, and CPTEG anhydride monomers. The results indicated that the amphiphilic environment provided by the CPTEG monomer was important to preserve the structure and antigenicity of both proteins. These studies offer an approach by which a thorough understanding of the mechanisms governing antigenic instability can be elucidated in order to optimize the in vivo performance of biodegradable delivery devices as protein carriers and/or vaccine adjuvants.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Yersinia bacterium, plague, ectoparasites research · Clostridium difficile and Clostridium perfringens research · Protein purification and stability
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Pharmaceutical biotechnology products approved within the European Union10.1016/S0939-6411(02)00165-0 ↗
2. Instability, stabilization, and formulation of liquid protein pharmaceuticals10.1016/S0378-5173(99)00152-0 ↗
3. Stability of peptides and proteins
4. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles10.1016/j.ejpb.2004.10.006 ↗
5. Stability of proteins and their delivery from biodegradable polymer microspheres
6. Sustained delivery of proteins for novel therapeutic products10.1126/science.281.5380.1161 ↗
7. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres10.1016/j.jconrel.2004.08.006 ↗
8. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation
9. Antigen stability controls antigen presentation10.1074/jbc.M405738200 ↗
10. Comparative studies on antigenicity and allergenicity of native and denatured egg white proteins10.1021/jf0112264 ↗
11. Contribution of conformational stability of hen lysozyme to induction of type 2 T-helper immune responses10.1046/j.1365-2567.2001.01314.x ↗
12. Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells10.1016/j.vaccine.2005.10.032 ↗
13. In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases
14. Protein stability in the presence of polymer degradation products: consequences for controlled release formulations10.1016/j.biomaterials.2006.01.054 ↗
15. Peptide, protein, and vaccine delivery from implantable polymeric systems
16. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins10.1023/A:1018876308346 ↗
17. In vitro release profiles of eristostatin from biodegradable polymeric microspheres: protein aggregation problem10.1021/bp00032a016 ↗
18. Stability and release of bovine serum albumin encapsulated within poly(d,l,-lactide-co-glycolide)microparticles10.1016/S0168-3659(96)01511-8 ↗
19. Polyanhydrides: an overview10.1016/S0169-409X(02)00050-9 ↗
20. Polyanhydrides
21. Molecular description of erosion phenomena in biodegradable polymers10.1021/ma047661r ↗
22. Polyanhydrides: the effects of ring substitution changes on polymer properties10.1007/s002890050435 ↗
23. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms10.1002/jbm.a.30510 ↗
24. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres10.1080/02652040601033841 ↗
25. Amphiphilic polyanhydrides for protein stabilization and release10.1016/j.biomaterials.2006.08.047 ↗
26. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis10.1128/iai.64.11.4580-4585.1996 ↗
27. Design and testing for a non-tagged F1–V fusion protein as vaccine antigen against bubonic and pneumonic plague10.1021/bp050098r ↗
28. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains10.1016/S0264-410X(00)00108-0 ↗
29. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia Pestis in mice10.4269/ajtmh.1998.58.793 ↗
30. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1–V antigen fusion protein vaccine10.1016/S0264-410X(98)80110-2 ↗
31. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1–V antigen fusion proteins for vaccination against plague10.1016/j.pep.2006.12.018 ↗
32. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens10.1128/IAI.73.8.5256-5261.2005 ↗
33. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery10.1016/j.vaccine.2006.01.031 ↗
34. LcrV plague vaccine with altered immunomodulatory properties10.1128/IAI.73.8.5152-5159.2005 ↗
35. Poly[1,3-bis(p-carboxyphenoxy)-propane anhydride]
36. Microphase separation in bioerodible copolymers for drug delivery10.1016/S0142-9612(00)00175-7 ↗
37. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery10.1016/S0142-9612(02)00181-3 ↗
38. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres10.1002/jbm.b.31478 ↗
39. Carrillo-Conde B, Garza A, Andergg J, Narasimhan B. Protein adsorption on biodegradable polyanhydride microspheres. J Biomed Mater Res A, submitted for publication.
40. Hydrogen-deuterium exchange in membrane proteins monitored by IR spectroscopy: a new tool to resolve protein structure and dynamics10.1002/bip.20035 ↗
41. FTIR determination of ligand-induced secondary and tertiary structural changes in bovine plasminogen10.1017/S0022029903006423 ↗
42. Circular dichroism
43. Yersinia pesits Yop secretion protein F: purification, characterization and protective efficacy against bubonic plague10.1016/j.pep.2005.02.016 ↗
44. Vaccine adjuvants: current challenges and future approaches10.1002/jps.21523 ↗
45. Biophysical characterization and formulation of F1–V, a recombinant plague antigen10.1002/jps.21652 ↗